—

Orion Oyj B (ORNBV.HE) — the peer cohort

As of 2026-11-16 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Orion Oyj B ranks 6 of 11 in its cohort on the Closelooknet composite (63/100) — the cohort is led by Halozyme Therapeutics Inc at 72/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
ORNBV.HE Orion Oyj B 63 95 84 28 ok 1%
LLY Eli Lilly and Company 64 91 90 22 bull 1%
ORNAV.HE Orion Oyj A 63 95 84 28 ok 1%
SAN.PA Sanofi SA 63 74 69 62 watch 1%
AZN.L AstraZeneca PLC 55 62 74 45 info 9.3%
GSK GSK plc 55 50 78 52 info 16.1%
AMGN Amgen Inc 54 87 84 34 neutral 3.8%
HALO Halozyme Therapeutics Inc 72 68 94 49 info 28%
ANN.AU Ansell Ltd 64 97 47 50 ok 1.7%
ARGX.BR Argen-X 64 79 75 25 ok 5.1%
UCB.BR UCB SA 64 75 70 42 info 2%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-16

Quick answers

Who are Orion Oyj B's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Eli Lilly and Company (LLY), Orion Oyj A (ORNAV.HE), Sanofi SA (SAN.PA), AstraZeneca PLC (AZN.L), GSK plc (GSK), Amgen Inc (AMGN), Halozyme Therapeutics Inc (HALO), Ansell Ltd (ANN.AU) and others, as of 2026-11-16.

How does ORNBV.HE score against its peers?

Orion Oyj B's composite reads 63/100, ranking 6 of 11 in its cohort as of 2026-11-16; the cohort's highest composite is Halozyme Therapeutics Inc at 72/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.